197 related articles for article (PubMed ID: 32802302)
1. Network Meta-Analysis of the Safety of Drug Therapy for Cardiogenic Shock.
Liao X; Qian L; Zhang S; Chen X; Lei J
J Healthc Eng; 2020; 2020():8862256. PubMed ID: 32802302
[TBL] [Abstract][Full Text] [Related]
2. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
Uhlig K; Efremov L; Tongers J; Frantz S; Mikolajczyk R; Sedding D; Schumann J
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009669. PubMed ID: 33152122
[TBL] [Abstract][Full Text] [Related]
3. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
Schumann J; Henrich EC; Strobl H; Prondzinsky R; Weiche S; Thiele H; Werdan K; Frantz S; Unverzagt S
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009669. PubMed ID: 29376560
[TBL] [Abstract][Full Text] [Related]
4. Comparative Effectiveness and Safety of Intermittent, Repeated, or Continuous Use of Levosimendan, Milrinone, or Dobutamine in Patients With Advanced Heart Failure: A Network and Single-Arm Meta-analysis.
Zhang X; Wang Z; Zhang L; Zhao X; Han Y
J Cardiovasc Pharmacol; 2024 Jul; 84(1):92-100. PubMed ID: 38547524
[TBL] [Abstract][Full Text] [Related]
5. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study.
Levy B; Perez P; Perny J; Thivilier C; Gerard A
Crit Care Med; 2011 Mar; 39(3):450-5. PubMed ID: 21037469
[TBL] [Abstract][Full Text] [Related]
6. Cardiology update. Drug therapy.
Tritschler I
Nurs Stand; 1993 Nov 10-16; 8(8):52. PubMed ID: 8260421
[No Abstract] [Full Text] [Related]
7. Comparative Effectiveness and Safety Between Milrinone or Dobutamine as Initial Inotrope Therapy in Cardiogenic Shock.
Lewis TC; Aberle C; Altshuler D; Piper GL; Papadopoulos J
J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):130-138. PubMed ID: 30175599
[TBL] [Abstract][Full Text] [Related]
8. [Management of cardiogenic shock: Results from a survey in France and Belgium].
Champion S; Deye N
Ann Cardiol Angeiol (Paris); 2017 Apr; 66(2):59-65. PubMed ID: 27836099
[TBL] [Abstract][Full Text] [Related]
9. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
Mathew R; Di Santo P; Jung RG; Marbach JA; Hutson J; Simard T; Ramirez FD; Harnett DT; Merdad A; Almufleh A; Weng W; Abdel-Razek O; Fernando SM; Kyeremanteng K; Bernick J; Wells GA; Chan V; Froeschl M; Labinaz M; Le May MR; Russo JJ; Hibbert B
N Engl J Med; 2021 Aug; 385(6):516-525. PubMed ID: 34347952
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
Biswas S; Malik AH; Bandyopadhyay D; Gupta R; Goel A; Briasoulis A; Fonarow GC; Lanier GM; Naidu SS
Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181
[TBL] [Abstract][Full Text] [Related]
11. [Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].
Meissner A; Schmelzle T; Simon R
Z Kardiol; 1996 Nov; 85(11):839-46. PubMed ID: 9064946
[TBL] [Abstract][Full Text] [Related]
12. Essential lessons in cardiogenic shock: epinephrine versus norepinephrine/dobutamine.
Krenn L; Delle Karth G
Crit Care Med; 2011 Mar; 39(3):583-4. PubMed ID: 21330855
[No Abstract] [Full Text] [Related]
13. Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality.
Tarvasmäki T; Lassus J; Varpula M; Sionis A; Sund R; Køber L; Spinar J; Parissis J; Banaszewski M; Silva Cardoso J; Carubelli V; Di Somma S; Mebazaa A; Harjola VP;
Crit Care; 2016 Jul; 20(1):208. PubMed ID: 27374027
[TBL] [Abstract][Full Text] [Related]
14. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
Potter BJ
N Engl J Med; 2021 Nov; 385(22):2107-2108. PubMed ID: 34818493
[No Abstract] [Full Text] [Related]
15. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
Gibson LE; Chang MG; Berra L
N Engl J Med; 2021 Nov; 385(22):2108. PubMed ID: 34818494
[No Abstract] [Full Text] [Related]
16. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock. Reply.
Mathew R; Di Santo P; Hibbert B
N Engl J Med; 2021 Nov; 385(22):2108-2109. PubMed ID: 34818495
[No Abstract] [Full Text] [Related]
17. Efficacy of epinephrine therapy in shock complicating pulmonary embolism.
Boulain T; Lanotte R; Legras A; Perrotin D
Chest; 1993 Jul; 104(1):300-2. PubMed ID: 8325096
[TBL] [Abstract][Full Text] [Related]
18. A Review of Inotropes and Inopressors for Effective Utilization in Patients With Acute Decompensated Heart Failure.
Nandkeolyar S; Ryu R; Mohammad A; Cordero-Caban K; Abramov D; Tran H; Hauschild C; Stoletniy L; Hilliard A; Sakr A
J Cardiovasc Pharmacol; 2021 Sep; 78(3):336-345. PubMed ID: 34117179
[TBL] [Abstract][Full Text] [Related]
19. The effects of Levosimendan on global haemodynamics in patients with cardiogenic shock.
Rokyta R; Pechman V
Neuro Endocrinol Lett; 2006; 27(1-2):121-7. PubMed ID: 16648778
[TBL] [Abstract][Full Text] [Related]
20. Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure.
Potapov EV; Hennig F; Wagner FD; Volk HD; Sodian R; Hausmann H; Lehmkuhl HB; Hetzer R
Eur J Cardiothorac Surg; 2005 May; 27(5):899-905. PubMed ID: 15848333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
